Growth Metrics

NeuroPace (NPCE) EBITDA Margin (2020 - 2026)

NeuroPace's quarterly EBITDA Margin came in at 25.23% in Q1 2026, down 238.0% year-on-year from 18.28% in Q1 2025, and down 279.65% quarter-over-quarter from 6.65% in Q4 2025.

NeuroPace has reported EBITDA Margin for 7 years, with the latest figure at 25.23% in Q1 2026.

  • For the quarter ending Q1 2026, EBITDA Margin fell 238.0% year-over-year to 25.23%; the trailing twelve-month figure through Mar 2026 stood at 16.84% (up 755.0% YoY), and the FY2025 full-year result was 16.34%, up 1078.0% from the prior year.
  • EBITDA Margin for Q1 2026 stood at 25.23%, down from 6.65% in the prior quarter.
  • The five-year high for EBITDA Margin was 6.65% in Q4 2025, with the low at 129.01% in Q2 2022.
  • Average EBITDA Margin over 5 years is 50.01%, with a median of 39.02% recorded in 2024.
  • Year-over-year, EBITDA Margin sank 6158 bps in 2022 and soared 7375 bps in 2023.
  • Tracing NPCE's EBITDA Margin over 5 years: stood at 85.39% in 2022, then soared by 60 bps to 34.42% in 2023, then soared by 51 bps to 17.02% in 2024, then soared by 61 bps to 6.65% in 2025, then tumbled by 280 bps to 25.23% in 2026.
  • The last three EBITDA Margin figures came in at 25.23% (Q1 2026), 6.65% (Q4 2025), and 9.51% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 12.05%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 15.55%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 16.24%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 21.16%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 28.97%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 14.52%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 21.42%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 10.04%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 19.94%
10 NeuroPace 558.86 Mn 504.88 Mn 18.05 Mn -25.23%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -25.23%
Dec 31, 2025 -6.65%
Sep 30, 2025 -9.51%
Jun 30, 2025 -29.01%
Mar 31, 2025 -22.85%
Dec 31, 2024 -17.02%
Sep 30, 2024 -20.15%
Jun 30, 2024 -39.02%
Mar 31, 2024 -49.24%
Dec 31, 2023 -34.42%
Sep 30, 2023 -44.18%
Jun 30, 2023 -55.26%
Mar 31, 2023 -71.69%
Dec 31, 2022 -85.39%
Sep 30, 2022 -104.58%
Jun 30, 2022 -129.01%
Mar 31, 2022 -107.01%
Dec 31, 2021 -100.01%
Sep 30, 2021 -77.97%
Jun 30, 2021 -67.43%
Mar 31, 2021 -78.54%
Dec 31, 2020 -42.65%
Sep 30, 2020 -32.28%
Jun 30, 2020 -114.61%
Mar 31, 2020 -67.99%